Product
Miebo
Name
MIEBO
INN Name
Perfluorohexyloctane
FDA Approved
Yes
3 clinical trials
1 organization
5 indications
1 document
Indication
Dry EyeIndication
EvaporativeIndication
Dry Eye SyndromeIndication
Dry Eye DiseaseIndication
Keratoconjunctivitis siccaClinical trial
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye DiseaseStatus: Recruiting, Estimated PCD: 2024-06-28
Clinical trial
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive AccuracyStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens WearersStatus: Completed, Estimated PCD: 2024-04-05
Document
DailyMed Label: MIEBOOrganization
BAUSCH & LOMB INCORPORATED